Monoclonal antibodies to stem cell factor receptors
CA 2107553 C · Owner: Lin, Nancy · Inventors: Broudy, Virginia C.; Lin, Nancy
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to monoclonal antibodies specific for a cell receptor specific for human stem cell factor (hSCF) as well as pharmaceutical compositions containing such monoclonal antibodies and uses of such monoclonal antibodies. These antibodies are useful for detecting the presence of stem cell factor receptors in a cell sample and for purifying hematopoietic cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 3, 1992 and granted July 31, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 3, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 3, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.